A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(34 sites)

United States

Vivent Health ( Site 1519), Denver, Colorado

Whitman-Walker Institute ( Site 1538), Washington D.C., District of Columbia

Midway Immunology and Research Center ( Site 1503), Ft. Pierce, Florida

CAN Community Health- Miami Gardens ( Site 1549), Miami Gardens, Florida

Orlando Immunology Center ( Site 1501), Orlando, Florida